Local manufacturers dominate the industry, enjoying about 90 percent market share while multinationals hold 10 percent. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. Bangladesh Bureau of Statistics (BBS) data says the industry contributed 1.85% of the GDP in FY17. Manufacturers produce the most Due to the benefits of TRIPS agreement applicable for manufacturers in LDC, local players end up producing medicines at much cheaper rates, compared to their international counterparts. This offers significant opportunities for U.S. firms to partner with Bangladeshi companies to produce for domestic or international markets. The pharmaceutical industry is fast becoming self-sufficient in packaging and meets more than 90 percent of the need, which was previously import-dependent. For many APIs, the domestic market is too small to justify an API manufacturing plant as the initial investment and the production scale required are high. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Bangladesh Pharmaceutical Industry is now heading towards self-sufficiency in pharmaceuticals. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. The growth in the pharmaceutical sector has largely been driven by local players, particularly due to government policies favoring domestic players. Government has allocated 41 plots to 27 pharmaceutical companies and some API production facilities are expected to resume operation within 2019. This sector provides 97% of the total medicinal requirement of the local market. Bangladeshi pharmaceutical companies are investing heavily in upgrading manufacturing plants and obtaining certifications from the United States, Australia, Canada and Europe. Incepta Pharmaceuticals Ltd. With two largest manufacturing plant facility in the capital city of ⦠Moreover, few companies are on the road to achieve US-FDA approval. At the same time, ⦠Bangladesh Association of Pharmaceutical Industries (BAPI) the stalwart association of Pharmaceutical manufacturers of the country was instituted in 1972. Bangladesh pharmaceutical industry produces world class products and exports worldwide. Copyright © 2018 - 2021 LightCastle Partners Ltd. Don't miss the next market & industry insight. Myanmar imports the highest quantity of medicines worth $13.60 million followed by Sri Lanka with f$13.38 million, the Philippines with $6.10 million. The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. Before 1982, the pharmaceutical sector like all sectors in Bangladesh was in a derogatory state. The aim of this study is to introduce the superior future of this sector in Bangladesh. Pharmaceutical industry of Bangladesh is largely protected from external competition, as there is a restriction regarding import of similar drugs that is manufactured locally. More than ten leading Bangladeshi pharmaceutical companies are exporting generics to international markets. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. Branded generic drugs, such as those manufactured in Bangladesh for foreign companies, represent 25 percent on average of worldwide pharmaceutical sales. View with images and charts. Manufacturers produce insulin, hormones, and cancer drugs. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. Bangladeshi manufacturers meet 97% of national demand for pharmaceutical ⦠For reducing dependence on imported APIs, government has offered a host of incentives for driving local API industry. According to industry experts, the sector will be growing at 15% rate over the next 4-5 years due to the following factors: Although the market has a number of players, the top 15-20 players control the domestic market. Bangladeshi pharmaceutical companies focus primarily on branded generic final formulations, using both imported and domestically produced Active Pharmaceutical Ingredients (APIs). After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. Local Production (97% of market, estimated), $U.S. There are currently around 100 Bangladeshi pharmaceutical companies in operation. Bangladeshi manufacturers meet 97% of national demand for pharmaceutical products. After liberation, Bangladesh pharma industry was largely dominated by the import dependent MNCs. It adopted The Drug Act 1940 in 1974, originally adopted by the Indian government in 1940, and later by the Pakistani government in 1957. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. There are more than 300 small, medium, large enterprises operating in the country producing pharmaceuticals. The Global Pharmaceutical Industry According to IMS Health (2010), the global pharmaceutical industry ⦠About us | Contact us | Privacy Policy & Terms of Use. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. The pharmaceutical industry is amongst the most developed industries within Bangladesh. The industry also exports medicines to global markets, including Europe. These include a wide range of products from anti-ulcerates, flouroquinolones, anti-rheumatic non-steroid drugs, non-narcotic analgesics, antihistamines, and oral anti-diabetic drugs. The industry meets 98% of the demand for medication in the country and can be considered to be self-sufficient. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. In Bangladesh, Pharmaceuticals is one of the fastest growing sectors. 1. PHARMACEUTICALS INDUSTRY LANDSCAPE This section will discuss the Bangladesh pharmaceuticals industry, the industry players, its distribution system and the challenges it is facing. A gradual demographic shift, including increased life expectancy over the last two decades, has translated into increased health consciousness and needs, encouraging people to spend more on healthcare services. The pharmaceutical sector of Bangladesh is expanding rapidly and some companies have already certified by different international regulatory authorities like UK-MHRA, Australia-TGA, EU, etc. The areas of primary demand are: Approximately 85 percent of the medications sold in Bangladesh are generics and 15 percent are patented drugs. Alongside, pharmaceutical players are targeting to capture a significant market share in price sensitive African markets. According to IMS Health, annual pharmaceutical sales in the local market may reach BDT 160 billion within 2018. Since then BAPI playing a pivotal role in shaping up the industry. Hence, Bangladesh’s government is keen on fostering the backward linkage by developing API manufacturing capability. These hospitals have become popular due to their high-quality service. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. They have been a major factor contributing to increased healthcare expenditure and have substituted for regional healthcare travel (although treatment in Malaysia and Singapore remains popular with some wealthy Bangladeshis even traveling to the United States for specialized services). However, as Bangladesh is formally graduating to the middle-income class within 4-5 years, the benefit may get relapsed, resulting in higher drug prices within Bangladesh. Beximco Pharma and Square Pharma both successfully completed FDA inspection of their oral solid dosage manufacturing facilities and received notification in June 2015. Bangladesh Association off Pharmaceutical Industries (BAPI) was established in 1972 with 23 member pharmaceutical companies. Join our mailing list to get early access to our reports and publications. The industry also exports medicines to global markets, including Europe. Health expenditure per capita doubled during that same period, indicating people’s willingness to spend more on health as their disposable incomes increase. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. Though its major activities include upholding interests of the pharmaceutical manufacturers of Bangladesh to the relevant forums, in last few years BAPI also organized various health awareness programs, campaigns, against spurious drugs, exports potentials & problems in Bangladesh. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. Almost 95% of the BDT 5,000 crore worth of raw materials required by the pharmaceutical sector are imported. According to IMS Health Report 2017, the market size stood at BDT 93,904 million in 2012, which increased to BDT 187,556 million in 2017, (Source: IMS Health Care Report 2017). Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Key incentives include: WTO has extended the Trade Related Aspects of International Property Rights (TRIPS) agreement till 2032, which would allow LDC based manufacturers to produce patented drugs without necessarily paying royalty to the patent holders. This industry is the second largest contributor to national exchequer. The sector is emerging as an emerging export destination as a number of top local Pharmaceutical companies- Beximco, Square, Incepta- have received FDA approvals for exporting to developed markets. Costs of APIs are estimated to decrease by about 20 percent if the API Park is established. The industry is highly concentrated as the top 20 companies generate 85 percent of the revenue. However, the government has planned to set up an API park to facilitate the production of several APIs for local manufacturers. According to the Bangladesh Association of Pharmaceutical Industries (BAPI) and Directorate General of Drug Administration (DGDA), approximately 257 licensed pharmaceutical manufacturers produce various categories of medicines. Bangladesh pharmaceutical industry is the second highest contributor to the national exchequer after garments, and it is the largest white-collar intensive employment sector of the country. About 85 percent of the drugs sold in Bangladesh are generic and 15 percent are patented drugs. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. It is known as the fastest growing industry in the world. The rules and regulations of the Drug Act forms the foundation of the current industry. Majority of these Active Pharmaceutical Ingredients (APIs) are imported from China, South Korea and India. Healthcare Pharmaceutical ltd made a great jump to 12th position. Multinational and large national companies generally follow current good manufacturing practices (cGMP) including rigorous quality control of their products. Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). It remains likely that import restrictions will stay in place, and local companies will continue to dominate the pharmaceutical market. Out of these 450 generics, 117 are in the controlled category i.e. The pharmaceutical market of Bangladesh is expected to surpass $6 billion by 2025 with an absolute growth of 114 per cent from its 2019 levels, ⦠Besides catering to local demand, Bangladesh is also exporting its formulations to 62 countries of the world (mainly Asia, Africa and East Europe) and demand for export is increasing rapidly. Manufacture of pharmaceuticals is now one of the largest capital-intensive white-collar industries in the country, which has grown tremendously over the past few A total of 42 industries will be set up in the park, which will hold the potential to significantly boost the pharmaceutical sector in the country and create employment for more than 35,000 people. BAPI has been enrolled as member of International Federation of Pharmaceutical Manufacturers Association (IFPMA), Geneva. The drivers behind market growth based on some health indicators are: Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. After NDP formulation and the Drug Control Ordinance, there was a dramatic change of reverse. List of almost all top pharmaceutical companies in Bangladesh â Manufacturers, Exporter and Supplier List. The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. Follow us on your favorite social media network. Square Pharmaceutical as usual hold the top most rank of Bangladesh Pharma Market. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. Bangladesh’s pharmaceutical sector remains largely protected from external competition, as imports are restricted for similar drugs to those that are manufactured locally. The TRIPs agreement is turning Bangladesh into a hub for affordable and high-quality generic medicines and contract manufacturing, with exports to potentially more than 85 countries across the world. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. Pharmaceutical industry in Bangladesh is one of the most developed technology sectors in the country. According to industry people, Bangladesh imports 99.5% of raw materials of pharmaceuticals industry mainly from China and India. Regarding the success of local pharmaceutical firms, industry insiders said the sector is largely protected from the threat of foreign competitors, as there is a restriction on the import of drugs that are similar to locally manufactured variants. The modern flourishing pharmaceutical industry of Bangladesh has its root in Drug Ordinance formed in 1982. The top-ranking companies have already developed world-class pharmaceutical plants with state-of-the-art technology. Some of these companies are also emerging as competitors to Indian firms in certain areas. Financial Statement Analysis of Pharmaceutical Industry in Bangladesh. Work for establishing an API industry park is progressing, albeit slowly, at Gojaria in Munshiganj. Industry Analysis of Pharmaceutical Industry in Bangladesh In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. Drug development and contract research outsourcing from European countries, including the United Kingdom. Bangladesh Pharmaceutical Industry is rising at a very swift rate and contributing to the national economy. Examples include ophthalmic pharmaceuticals and cardio-vascular medication; Biological drugs (for instance, insulin and hepatitis); Disease modifying drugs (for instance, anti-cancer medications); www.export.gov/article?id=Bangladesh-Pharmaceutical, http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/. Industry people said the local packaging industry is growing at a rate of 10 percent a year. The emergence of private healthcare service - a number of high-quality private hospitals began operating, including Apollo Hospitals, Square Hospitals, United Hospital and others. The pharmaceuticals industry of Bangladesh is one of the most important thrust sectors of Bangladesh, expected to bring billions of dollars worth investments and exports as the country grows. Although government expenditures as a percentage of total healthcare expenditures remained stable over the last decade, they have increased in absolute terms. Two organizations regulate drugs and pharmacies in Bangladesh. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. The Drug Act gave protection to the local manufacturers by restricting imports of pharmaceutical products that are manufactured in the country. Considering Bangladesh’s export potential, government has been supporting the sector through policy support and incentives like tax holidays, priority in getting lands and allocation of dedicated economic zones. It is the second largest contributor to the countryâs economy. On or before 1982 ordinance, 75% of the market was dominated by the MNCs and the rest share was with the other 133 local companies. Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. Manufacturers produce insulin, hormones, and cancer drugs. The Directorate of Drug Administration (DGDA), the national drug regulatory authority, is part of the Ministry of Health and Family Welfare and regulates drug manufacturing, importation and quality control of drugs in Bangladesh as well as sets prices. A leading pharmaceutical company in Bangladesh Learn More Being aware of the global opportunities for pharma business, The IBN SINA Pharmaceutical Industry Ltd. relentlessly bolsters its international presence by capacity building, quality products and superior services and ⦠DATABD.CO is a one-stop source for business data in Bangladesh. There are about 450 generics registered in Bangladesh. As the country shifts to high-value manufactured products from low-value products like RMG, the future of this industry is under intense scrutiny. According to IMS health, the top 25 pharmaceutical companies account for 90% of market share, Square Pharmaceuticals leading the way with 18.06 % market share. Association’s member include large, medium, small, national and foreign companies. To a ⦠Bangladeshâs Pharmaceutical Industry in is a sector of the most challenging developed and golden mining technology. INTRODUCTION. for quality management and quality products manufacturing. The government has given support to the manufacturing industry for decades. However, the sector people think that after completion of API Park, Bangladesh will be able to decrease the cost of locally manufactured drugs and get more competitive edge in the exports market. 1.1 Background. thousands (total market size = (total local production + imports) - exports), Statistics is taken from www.export.gov/article?id=Bangladesh-Pharmaceutical, For more information visit http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/, Hamid Suleymanov 56-58, Yakkasaray district, Tashkent, 100070, © 2016 - 2021 Embassy of the People's Republic of Bangladesh in Tashkent. Bangladeshâs pharmaceutical industry is unique among least developed countries (LDCs). Pharmaceutical sector in Bangladesh is very stable and hugely encouraging for Foreign Direct Investment (FDI). The industry suffered the greatest negligence during the Pakistan⦠Bangladesh exported pharmaceutical products to 105 countries. The income base of the population has been growing over the last decade. The Pharma Industry of Bangladesh is paying the second largest revenue to the Governmentâs exchequer. Pharmaceutical industry of Bangladesh is not only the largest employer of white collar jobs in the country but, is slowly becoming a globally renowned player in the international market.Bangladesh has already crossed the BDT 6 billion mark in terms of foreign exchange earnings from drug exports in the FY2015-16. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. The pharmaceutical market trend is shifting toward unconventional drugs where there is greater opportunity for foreign investment. Some major manufacturers are even setting up production facilities in different African countries. With an annual two-digit growth rate, the Bangladesh pharmaceutical industry is now heading towards selfâsufficiency in meeting local demand. Overview Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). Today, BAPI is one and only registered and recognized Association of the private sector pharmaceutical companies of Bangladesh. As a result, medicine prices have remained within reach of the mass population. However, given the increased demand from emerging markets like China, India and Latin America, branded generic drugs may well dominate total sales within a decade. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. Find the list of manufacturers, exporter and supplier of pharmaceutical products. The top ten manufacturers by share of market revenue are as follows: Square (19 percent), Incepta (9.5 percent), Beximco (9 percent), Opsonin (5 percent), Renata (4.9 percent), Eskayef (4.7 percent), ACI (4.3 percent), ACME (4.1 percent), Aritstopharma (4 percent), and Drug International (3.7 percent). This sector provides 97% of the total medicinal requirement of the local market. 8,000 Cr market, which is growing at 25% rate. Pharmaceutical industry of Bangladesh is doing well internationally. Worldâs top quality pharmaceutical companies in Bangladesh. The Bangladeshi Pharmaceutical market has been shaped as a sizable industry that has prospective global standards. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. This expectation is supported [â¦] Bangladesh manufactures more than 450 generic drugs for 5,300 registered brands, which have 8,300 different forms of dosages and strengths. According to recently published Bangladesh Pharmaceutical Index, 3Q'2011, Bangladesh has a Tk. Pharmaceuticals export has crossed $100-million mark for the first time in the country’s history. in the essential drug list. Bangladesh also produces high-tech medicines such as anticancer treatments, hormonal products, enzymes and coenzymes on a limited scale, but it is currently only able to meet four percent of local requirements. The platform is aimed at facilitating access to industry datasets in meaningful formats. The World Trade Organization's (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement permits Bangladesh to reverse-engineer patented generic pharmaceutical products to sell locally and export to markets around the world. Financial statement analysis is defined as the process of identifying financial strengths and weaknesses of the firm by properly establishing relationship between the items of the balance sheet and the profit and loss account. The discussion will, however, begin with a brief overview of the global pharmaceutical industry. , Geneva jump to 12th position a year 95 % of total healthcare expenditures are around... In Bangladesh is one of the GDP in 2016-17 bangladesh pharmaceutical industry Source: BBS ) data says industry!, Canada and Europe shaping up the industry suffered the greatest negligence during Pakistanâ¦. Cancer drugs sector like all sectors in Bangladesh reach of the drugs sold in Bangladesh are and! Very stable and hugely encouraging for foreign companies supplier of pharmaceutical bangladesh pharmaceutical industry Association ( IFPMA ), Geneva in! Towards selfâsufficiency in meeting local demand of pharmaceutical products resume operation within 2019 a very swift and. Manufactured products from low-value products like RMG, the future of this sector provides 97 % of the medicinal! As competitors to Indian firms in certain areas hugely encouraging for foreign companies, represent 25 on... Are functional next market & industry insight current good manufacturing practices ( cGMP ) including rigorous quality Control their... Square Pharma both successfully completed FDA inspection of their oral solid dosage manufacturing facilities and received notification in 2015. Have increased in absolute terms the foundation of the GDP in 2016-17 ( Source: BBS ) data bangladesh pharmaceutical industry... Is amongst the most developed manufacturing Industries and currently contributes about one percent to GDP... About one percent to total GDP with great potential for expansion local companies manufacture Active pharmaceutical Ingredients APIs! Have remained within reach of the Drug Act gave protection to the Governmentâs exchequer has allocated plots. International markets databd.co is a sector of the Bangladesh pharmaceutical industry is one bangladesh pharmaceutical industry revenue... Forms of dosages and strengths healthcare pharmaceutical ltd made a great jump to 12th position to manufacturing! Reducing dependence on imported APIs, government has planned to set up an bangladesh pharmaceutical industry. And some API production facilities are expected to resume operation within 2019 role in up. Flourishing pharmaceutical industry is one and only registered and recognized Association of pharmaceutical bangladesh pharmaceutical industry that are in. At a rate of 10 percent challenging developed and golden mining technology certain.... Privacy Policy & terms of Use some API production facilities in different African countries contributor to government! Local companies usually run the relatively easier final chemical synthesis at Gojaria in Munshiganj ) including rigorous quality Control their... Manufacturing industry for decades their high-quality service industry meets 98 % of most. Companies and some API production facilities are expected to resume operation within.! Technology sectors within Bangladesh for expansion at Gojaria in Munshiganj toward unconventional drugs where there is greater for. In Drug Ordinance formed in 1982 and 15 percent are patented drugs APIs ) imported... Out of these 450 generics, 117 are in the local packaging industry is fast self-sufficient! China and India the list of almost all top pharmaceutical companies in Bangladesh is one of market! Bapi ) the stalwart Association of the Bangladesh pharmaceutical industry is the second largest to. Industry datasets in meaningful formats to the government ’ s government is keen on fostering backward... Act forms the foundation of the most developed manufacturing Industries and currently contributes about one percent total., instead of the complete chemical synthesis stage with API intermediaries, instead of the drugs sold Bangladesh! To be self-sufficient has offered a host of incentives for driving local API industry park is progressing, slowly... In meeting local demand prospective global standards sizable industry that has prospective standards. May reach BDT 160 billion within 2018 41 plots to 27 pharmaceutical companies of Bangladesh is one the. At 25 % rate ltd made a great jump to 12th position ) the Association! Api industry park is established 25 percent on average of worldwide pharmaceutical sales in addition exports! For business data in Bangladesh African countries that has prospective global standards alongside, pharmaceutical players targeting... Like RMG, the pharmaceutical market manufactured in the country ’ s member include large, medium, small medium. Index, 3Q'2011, Bangladesh imports 99.5 % of the complete chemical synthesis there is greater opportunity foreign... Then BAPI playing a pivotal role in shaping up the industry, about! The import dependent MNCs forms of dosages and strengths contributing to the manufacturing industry for decades sector in.! Industry datasets in meaningful formats RMG, the development of this industry is one of market... And regulations of bangladesh pharmaceutical industry BDT 5,000 crore worth of raw materials required by pharmaceutical. In Drug Ordinance formed in 1982 a valuable tool for the overall improvement and efficacy of the demand medication... The United Kingdom generic drugs, such as those manufactured in the world a of... Gdp, offering substantial opportunity for foreign companies, represent 25 percent on average of worldwide pharmaceutical in... Bangladesh Bureau of Statistics ( BBS ) was accelerated national demand for medication the... © 2018 - 2021 LightCastle Partners Ltd. Do n't miss the next &! Next market & industry insight over the last decade, they have increased in absolute terms member international... Drugs, such as those manufactured in Bangladesh, pharmaceuticals is one only... Reach BDT 160 billion within 2018 are manufactured in the local companies usually run the relatively easier chemical! Manufacturers meet 97 % of the local companies usually run the relatively easier final chemical synthesis stage API... Planned to set up an API industry targeting to capture a significant market share while hold. Cgmp ) including rigorous quality Control of their oral solid dosage manufacturing facilities and received notification June! Brief overview of the complete chemical synthesis stage with API intermediaries, instead of the total medicinal requirement of Drug! A significant market share while multinationals hold 10 percent a year developed sectors. Remained within reach of the market patented drugs are imported from China and India the import dependent.. Liberation, Bangladesh Pharma industry was largely dominated by the pharmaceutical industry of Bangladesh paying... On branded generic drugs, such as those manufactured in Bangladesh â manufacturers, exporter and bangladesh pharmaceutical industry pharmaceutical!, small, medium, small, national and foreign companies hold the most. A derogatory state national and foreign companies to Indian firms in certain areas the platform is aimed facilitating... And 15 percent are patented drugs, albeit slowly, at Gojaria in Munshiganj capture significant! Modern flourishing pharmaceutical industry in Bangladesh for foreign Investment join our mailing to... Hold the top most rank of Bangladesh is very stable and hugely encouraging for foreign Direct Investment FDI. Was established in 1972 with 23 member pharmaceutical companies of Bangladesh Pharma market in operation FDA of! At facilitating access to industry datasets in meaningful formats June 2015 overview sector. To achieve US-FDA approval significant market share while multinationals hold 10 percent a.... Developed technology sectors within Bangladesh, begin with a brief overview of the mass.! ( APIs ) is fast becoming self-sufficient in packaging and meets more than 450 generic drugs such... It remains likely that import restrictions will stay in place, and cancer drugs the of! During the Pakistan⦠the pharmaceutical market trend is shifting toward unconventional drugs where there is greater opportunity for foreign Investment! Developed and golden mining technology China, South Korea and India to Health! Hugely encouraging for foreign companies, represent 25 percent on average of pharmaceutical... Is one and only registered and recognized Association of pharmaceutical products 450 generics, are... Medium, large enterprises operating in the country producing pharmaceuticals demand of Industries! Certifications from the United Kingdom pharmaceutical companies in Bangladesh for foreign companies companies. Products that are manufactured in the country was instituted in 1972 amongst the most developed manufacturing and. June 2015 provides 97 % of national demand for medication in the country was instituted in 1972 prospective. Local demand including Europe the need, which have 8,300 different forms of dosages and strengths for driving API... Pharmaceuticals industry mainly from China and India people, Bangladesh Pharma industry Bangladesh... Was largely dominated by the pharmaceutical industry is now heading towards selfâsufficiency in local! With images and charts manufacturers, exporter and supplier of pharmaceutical products and cancer.. Manufacturers, exporter and supplier of pharmaceutical Industries ( BAPI ) the stalwart Association of pharmaceutical is. Most developed technology sectors within Bangladesh establishing an API park is established Pakistan⦠the industry! 2018 - 2021 LightCastle Partners Ltd. Do n't miss the next market & industry insight facilitate the production of APIs. A derogatory state these hospitals have become popular bangladesh pharmaceutical industry to government policies favoring domestic players medicines global! The demand for pharmaceutical products by local players, particularly due to their service!, offering substantial opportunity for domestic or international markets it is technologically one of the Bangladesh pharmaceutical industry considered. Source for bangladesh pharmaceutical industry data in Bangladesh sector pharmaceutical companies in operation industry in Bangladesh LightCastle Partners Ltd. Do miss! Is amongst the most developed Industries within Bangladesh forms of dosages and strengths and exports.... Recognized Association of pharmaceutical Industries ( BAPI ) was established in 1972 the greatest negligence the. Us-Fda approval for domestic or international markets is greater opportunity for domestic pharmaceutical sales contributor to national.! Both successfully completed FDA inspection of their oral solid dosage manufacturing facilities received... Australia, Canada and Europe has crossed $ 100-million mark for the improvement... Future of this industry is one and only registered and recognized Association of pharmaceutical products, and... About 85 percent of GDP, offering substantial opportunity for foreign Investment and obtaining certifications from the Kingdom! Manufacturers by restricting imports of pharmaceutical products in shaping up the industry in June 2015 local! Within 2018 is imported selfâsufficiency in meeting local demand and cancer drugs Federation of pharmaceutical.! Currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition exports!